Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Lidocaine for Postoperative Recovery in Laparoscopic Cholecystectomy
NCT07150481Phase 3Not yet recruiting
- Sponsor
- Assiut University
- Start
- Oct 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain, post-operative inflammation, sponsored by Assiut University. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative painpost-operative inflammation
Beyond the preview
Go deeper on NCT07150481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07150481.